Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
about
Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?Pharmacological Basis for Use of Armillaria mellea Polysaccharides in Alzheimer's Disease: Antiapoptosis and Antioxidation.Astrocyte-specific overexpression of Nrf2 protects against optic tract damage and behavioural alterations in a mouse model of cerebral hypoperfusion
P2860
Oral administration of methysticin improves cognitive deficits in a mouse model of Alzheimer's disease.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Oral administration of methyst ...... model of Alzheimer's disease.
@ast
Oral administration of methyst ...... model of Alzheimer's disease.
@en
type
label
Oral administration of methyst ...... model of Alzheimer's disease.
@ast
Oral administration of methyst ...... model of Alzheimer's disease.
@en
prefLabel
Oral administration of methyst ...... model of Alzheimer's disease.
@ast
Oral administration of methyst ...... model of Alzheimer's disease.
@en
P2093
P2860
P1433
P1476
Oral administration of methyst ...... model of Alzheimer's disease.
@en
P2093
Athanassios Fragoulis
Christoph Jan Wruck
Joachim Weis
Lars-Ove Brandenburg
Markus Fendt
Sandra Jansen
Stephanie Siegl
Thomas Pufe
P2860
P304
P356
10.1016/J.REDOX.2017.04.024
P577
2017-04-19T00:00:00Z